Sponsor:
NYU Langone Health
Code:
NCT05815173
Conditions
Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Sotorasib
Ladarixin
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-04-17. This information was provided to ClinicalTrials.gov by NYU Langone Health on 2025-02-19.